催化抗体生物结合
Vlad Bacauanu1, Zoe N Merz1, Zhong L Hua2
1Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States.
Journal of the American Chemical Society
|November 11, 2023
概括
研究人员开发了一种使用催化剂修改蛋白质的新生物相容方法. 这种技术可以产生具有向癌细胞杀伤能力的先进抗体-药物联合体 (ADC).
科学领域:
- 生物化学
- 有机化学
- 化学生物学
背景情况:
- 开发生物相容的蛋白质修饰方法对于创建先进的化学探测器和生物疗法至关重要.
- 抗体与药物结合剂 (ADC) 是新一代疗法的一类,需要有效的生物结合策略.
研究的目的:
- 开发一种新的,水性,催化交叉合方法,用于对和蛋白质的囊残留物进行特定的合.
- 证明这个平台在制备抗体与药物合物 (ADC) 的有用性.
主要方法:
- 一个水性催化交叉合反应的自下而上的构造.
- 在和蛋白质中的囊残留物的化学特异性化.
- 包含多种类型的链,小分子,探针和细胞毒性有效载荷.
- 准备和评估新的ADC.
主要成果:
- 在和蛋白质上成功证明了水性催化.
- 包括细胞毒剂在内的各种链和功能有效载荷的多功能结合.
- 构建具有被证明具有目标介导的细胞毒性活性的新型ADC.
结论:
- 开发的生物结合平台提供了一种新的,生物相容的蛋白质修饰方法.
- 这种方法有助于制备具有潜在治疗用途的多种ADC.
- 该方法对药物发现有价值,使其能够创建具有强大的细胞毒性活性的新型ADC.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.5K
相关概念视频
01:10Antibody Structure
52.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
52.5K
01:33Enzyme-Linked Immunosorbent Assay
14.2K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
14.2K
01:26Antibody Actions
3.9K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.9K